Matches in Nanopublications for { ?s ?p "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284578.RARJlHAwY9j_u1fEcGvZxIJIwlBWT135wfWyT3R72zmvk130_assertion description "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284578.RARJlHAwY9j_u1fEcGvZxIJIwlBWT135wfWyT3R72zmvk130_provenance.
- assertion description "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP733959.RAQg-hpMFEi75sQcM7O1vX-yYhaxEOovde7lNMHEugkaw130_assertion description "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733959.RAQg-hpMFEi75sQcM7O1vX-yYhaxEOovde7lNMHEugkaw130_provenance.
- NP830251.RALOtBJF50vVXD4kU2FTm9Q_AV0okhFzPxP-B4gS93ThI130_assertion description "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830251.RALOtBJF50vVXD4kU2FTm9Q_AV0okhFzPxP-B4gS93ThI130_provenance.
- NP481494.RAwRXDW68R4rp4HBcl9r45baz584B59mQBiGZn-VGspI8130_assertion description "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481494.RAwRXDW68R4rp4HBcl9r45baz584B59mQBiGZn-VGspI8130_provenance.
- NP733958.RAFbKQ3tH5lzAgicroL0ug2ugR6tgy2sGpuGAHhyBRYgQ130_assertion description "[IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733958.RAFbKQ3tH5lzAgicroL0ug2ugR6tgy2sGpuGAHhyBRYgQ130_provenance.